Frequently Asked Questions
The market is segmented based on , By Test Type (Nucleic Acid Amplification, Gram Stain, Enzyme-linked immunosorbent assay, Gonorrhea Culture, and Rapid Test), Sample Type (Blood, Lymph Fluid, Urine, Throat Swab, and Penis/Vaginal Swab), End-User (Hospitals, Pathology Labs and Point of Care Testing) – Industry Trends and Forecast to 2030.
.
The Global Gonorrhea Testing Market size was valued at USD 8.13 USD Billion in 2022.
The Global Gonorrhea Testing Market is projected to grow at a CAGR of 8.5% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott , Aposcience , BD , Biocartis , bioMé,rieux , Bio-Rad LaboratoriesInc , Cepheid , Danaher , DiaSorin S.p.A , GenMark DiagnosticsInc. , Hologic Inc. , OraSure Technologies Inc. , Qualigen Technologies Inc. , Quidel Corporation , F. Hoffmann-La Roche Ltd , Thermo Fisher Scientific Inc , MedMira Inc. .
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
